Skip to content

13F-HR filed by Sio Capital Management, LLC

Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 62 holding rows worth $266,238,000.

Accession
0001214659-22-010095
Filed
2022-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 62 entries on the cover page, a total value of $266,238,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $266,238,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CENCORA INC COM03073E105Stock183,334$25,938,000thousands by filing date
MEDICUS SCIENCES ACQUISITIONG5960S108CL A SHS2,323,000$22,719,000thousands by filing date
ORGANON & CO COMMON STOCK68622V106Stock574,855$19,401,000thousands by filing date
Cigna Corporation125523100COM53,034$13,976,000thousands by filing date
INOGEN INC45780L104COM525,438$12,705,000thousands by filing date
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS688,989$11,561,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock129,011$10,916,000thousands by filing date
HCA Healthcare Inc40412C101COM61,953$10,412,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock39,959$9,416,000thousands by filing date
BAUSCH HEALTH COS INC COM071734107Stock1,042,700$8,717,000thousands by filing dateput
INARI MED INC45332Y109COM112,466$7,647,000thousands by filing date
BIOGEN INC COM09062X103Stock35,900$7,321,000thousands by filing date
Medtronic PlcG5960L103COM80,000$7,180,000thousands by filing date
SIGHT SCIENCES INC82657M105COMMON STOCK724,944$6,517,000thousands by filing date
NATUS MEDICAL INC639050103COM190,956$6,258,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM119,061$6,223,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock105,000$5,519,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM488,965$5,330,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM35,000$5,100,000thousands by filing date
SKINHEALTH SYSTEMS INC88331L108COM CL A362,294$4,659,000thousands by filing date
INHIBRX INC45720L107COM365,210$4,145,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock40,725$4,101,000thousands by filing date
HESKA CORP42805E306COM39,566$3,739,000thousands by filing date
POINT BIOPHARMA GLOBAL INC730541109COM504,545$3,436,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS40,000$3,190,000thousands by filing date
MODULAR MED INC60785L207COM NEW574,352$2,975,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM999,829$2,890,000thousands by filing date
PROMETHEUS BIOSCIENCES INC74349U108COM101,600$2,868,000thousands by filing dateput
EUCRATES BIOMEDICAL ACQU CORG3141W114UNIT 10/23/2027248,674$2,492,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS250,000$2,490,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM4,668,536$2,358,000thousands by filing date
AFFIMED N VN01045108COM821,065$2,274,000thousands by filing date
MERUS N VN5749R100COM87,953$1,991,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM555,610$1,639,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM1,008,993$1,614,000thousands by filing date
MOLECULIN BIOTECH INC60855D200COMMON1,036,853$1,503,000thousands by filing date
RENOVACOR INC75989E106COM735,908$1,492,000thousands by filing date
SAVARA INC805111101COM856,428$1,302,000thousands by filing date
ANI PHARMACEUTICALS INC00182C103COM40,000$1,187,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK58,556$1,163,000thousands by filing date
TYRA BIOSCIENCES INC90240B106COMMON STOCK152,159$1,088,000thousands by filing date
PARDES BIOSCIENCES INC69945Q105COM315,564$969,000thousands by filing date
Ohr Pharmaceutical Inc64132K102COM906,445$952,000thousands by filing date
ISOPLEXIS CORP465005106COM407,102$879,000thousands by filing date
IVERIC BIO INC46583P102COM86,400$831,000thousands by filing dateput
FUSION PHARMACEUTICALS INC36118A100COM260,448$649,000thousands by filing date
ASLAN PHARMACEUTICALS LTD04522R101ADR1,270,758$629,000thousands by filing date
NEXTCURE INC65343E108COM130,000$611,000thousands by filing date
CONNECT BIOPHARMA HLDGS LTD207523101SHS597,678$520,000thousands by filing date
ELEVATION ONCOLOGY INC COM28623U101Stock359,731$504,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock16,368$498,000thousands by filing date
CYCLACEL PHARMACE 6percent PFDCONV23254L603Stock454,355$491,000thousands by filing date
ARDELYX INC039697107COM692,357$408,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM276,909$267,000thousands by filing date
NYXOAH S AB6S7WD106SHS16,110$148,000thousands by filing date
VINCERX PHARMA INC92731L106COM NEW102,049$135,000thousands by filing date
CAREMAX INC14171W103COM30,741$112,000thousands by filing date
BAUSCH HEALTH COS INC COM071734107Stock6,700$56,000thousands by filing date
Humacyte Inc W Exp 08/27/20244486Q111SPAC Combination49,998$45,000thousands by filing date
NEOLEUKIN THERAPEUTICS INC64049K104COM38,312$39,000thousands by filing date
Renovacor Inc75989E114Warrant400,000$34,000thousands by filing date
CAREMAX INC14171W111*W EXP 06/08/20212,808$9,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-22-010095this filing2022-08-15acceptance time not in the bulk data set